These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 26996268

  • 41. Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trial.
    Moss RB, Flume PA, Elborn JS, Cooke J, Rowe SM, McColley SA, Rubenstein RC, Higgins M, VX11-770-110 (KONDUCT) Study Group.
    Lancet Respir Med; 2015 Jul; 3(7):524-33. PubMed ID: 26070913
    [Abstract] [Full Text] [Related]

  • 42. Sweat chloride as a biomarker of CFTR activity: proof of concept and ivacaftor clinical trial data.
    Accurso FJ, Van Goor F, Zha J, Stone AJ, Dong Q, Ordonez CL, Rowe SM, Clancy JP, Konstan MW, Hoch HE, Heltshe SL, Ramsey BW, Campbell PW, Ashlock MA.
    J Cyst Fibros; 2014 Mar; 13(2):139-47. PubMed ID: 24660233
    [Abstract] [Full Text] [Related]

  • 43. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
    Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, Sagel SD, Hornick DB, Konstan MW, Donaldson SH, Moss RB, Pilewski JM, Rubenstein RC, Uluer AZ, Aitken ML, Freedman SD, Rose LM, Mayer-Hamblett N, Dong Q, Zha J, Stone AJ, Olson ER, Ordoñez CL, Campbell PW, Ashlock MA, Ramsey BW.
    N Engl J Med; 2010 Nov 18; 363(21):1991-2003. PubMed ID: 21083385
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. A multicenter evaluation of sweat chloride concentration and variation in infants with cystic fibrosis.
    LeGrys VA, Moon TC, Laux J, Accurso F, Martiniano SA.
    J Cyst Fibros; 2019 Mar 18; 18(2):190-193. PubMed ID: 30583934
    [Abstract] [Full Text] [Related]

  • 46. Phenotypic characterisation of patients with intermediate sweat chloride values: towards validation of the European diagnostic algorithm for cystic fibrosis.
    Goubau C, Wilschanski M, Skalická V, Lebecque P, Southern KW, Sermet I, Munck A, Derichs N, Middleton PG, Hjelte L, Padoan R, Vasar M, De Boeck K.
    Thorax; 2009 Aug 18; 64(8):683-91. PubMed ID: 19318346
    [Abstract] [Full Text] [Related]

  • 47. Efficacy response in CF patients treated with ivacaftor: post-hoc analysis.
    Konstan MW, Plant BJ, Elborn JS, Rodriguez S, Munck A, Ahrens R, Johnson C.
    Pediatr Pulmonol; 2015 May 18; 50(5):447-55. PubMed ID: 25755212
    [Abstract] [Full Text] [Related]

  • 48. CFTR modulation with elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis assessed by the β-adrenergic sweat rate assay.
    Pallenberg ST, Junge S, Ringshausen FC, Sauer-Heilborn A, Hansen G, Dittrich AM, Tümmler B, Nietert M.
    J Cyst Fibros; 2022 May 18; 21(3):442-447. PubMed ID: 34756683
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Ivacaftor: the first therapy acting on the primary cause of cystic fibrosis.
    McPhail GL, Clancy JP.
    Drugs Today (Barc); 2013 Apr 18; 49(4):253-60. PubMed ID: 23616952
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis.
    Altes TA, Johnson M, Fidler M, Botfield M, Tustison NJ, Leiva-Salinas C, de Lange EE, Froh D, Mugler JP.
    J Cyst Fibros; 2017 Mar 18; 16(2):267-274. PubMed ID: 28132845
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.
    Zeybel GL, Pearson JP, Krishnan A, Bourke SJ, Doe S, Anderson A, Faruqi S, Morice AH, Jones R, McDonnell M, Zeybel M, Dettmar PW, Brodlie M, Ward C.
    J Cyst Fibros; 2017 Jan 18; 16(1):124-131. PubMed ID: 27475719
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.